Back

Inferring vaccine efficacy and mode of action from human challenge studies

Miura, F.; Klinkenberg, D.; Ainslie, K. E. C.; Backer, J. A.; Leung, K. Y.; McDonald, S. A.; de Boer, P. T.; Wallinga, J.

2023-09-25 infectious diseases
10.1101/2023.09.24.23296054 medRxiv
Show abstract

To assess the long-term effect of a vaccination programme, understanding both the efficacy and the mode of action of the vaccine is crucial. The actual mode of action is difficult to infer from field trials, because of the heterogeneity of exposure to infection. Here we show an approach to determine both vaccine efficacy and the mode of action of vaccines from human challenge studies. Our approach reveals how vaccines alter an individuals susceptibility, and identifies a mixture of different modes of action as a function of the challenged dose. By applying the proposed method to influenza challenge data, we illustrate that potentially the lowest vaccine efficacy may occur at intermediate doses, suggesting a hypothesis that moderate transmission intensities might be optimal for establishing infections in vaccinated individuals. One sentence summaryHuman challenge studies reveal the protection mechanism of vaccines by measuring variation in susceptibility to infection.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.